The European respiratory device market was valued at around $5.8 billion in 2018 and is estimated to grow at a CAGR of around 5.8% during the forecast period. Major countries that contribute to the regional respiratory device market include UK, Germany, France, Italy, and Spain. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in Europe. The increasing demand from chronic obstructive pulmonary disease (COPD), Sleep Apnea and asthma patients in the major economies of the region is favoring the growth of the regional market.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/european-respiratory-device-market

The European respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the regional market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/european-respiratory-device-market

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include ResMed Corp., Chiesi Farmaceutici S.P.A., GlaxoSmithKline PLC, 3M Co., Novartis AG, Teicos Pharma Ltd., and others. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. For instance, in September 2017, Chiesi Farmaceutici completed the clinical study of Tribute with its Trimbow an extra-fine fixed-dose triple combination inhaler. The organization also got the marketing authorization for Trimbow from the European Commission. In November 2016, the company acquired Atopix therapeutics limited, the transaction aimed to develop novel treatments for asthma and strengthen the company’s asthma portfolio.

Market Segmentation

European Respiratory Device Market by Product
Therapeutic Devices
Diagnostic and Monitoring Devices
Consumable and Accessories
European Respiratory Device Market by End-User
Homecare
Hospitals and Clinics
Regional Analysis

UK
Germany
France
Italy
Spain
Rest of Europe
Company Profiles

3M Co.
Acorda Therapeutics, Inc.
Adamis Pharmaceuticals Corp.
Adherium Ltd.
Air Liquide S.A.
AstraZeneca PLC
Bespak
Boehringer Ingelheim International GmbH
Chiesi Farmaceutici S.P.A.
Gilbert Technologies B.V.
GlaxoSmithKline PLC
H&T Presspart Manufacturing Ltd.
Hamilton Medical AG
Koninklijke Philips N.V.
Medtronic PLC
Novartis AG
PMD Device Solutions Ltd.
ResMed Corp.
Savara, Inc.
Teicos Pharma Ltd.
Teva Pharmaceuticals Industries Ltd.
Vitalograph Ltd.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-respiratory-device-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari

Email: [email protected]
Contact no: +91 780-304-0404